Terms: = Thyroid cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
85 results:
1. A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer.
Han PZ; Ye WD; Yu PC; Tan LC; Shi X; Chen XF; He C; Hu JQ; Wei WJ; Lu ZW; Qu N; Wang Y; Ji QH; Ji DM; Wang YL
JCI Insight; 2024 Mar; 9(8):. PubMed ID: 38478516
[TBL] [Abstract] [Full Text] [Related]
2. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
3. A novel bystander effect in tamoxifen treatment: PPIB derived from ER+ cells attenuates ER- cells via endoplasmic reticulum stress-induced apoptosis.
Yang T; Li W; Zhou J; Xu M; Huang Z; Ming J; Huang T
Cell Death Dis; 2024 Feb; 15(2):147. PubMed ID: 38360722
[TBL] [Abstract] [Full Text] [Related]
4. Killing capacity analysis of tumor-infiltrating cytotoxic lymphocytes and impact on lymph node metastasis in differentiated papillary carcinoma of thyroid with the BRAF V600E mutation.
Liu X; Liu H; Wang L; Han Y; Kong L; Zhang X
Diagn Pathol; 2024 Feb; 19(1):29. PubMed ID: 38341587
[TBL] [Abstract] [Full Text] [Related]
5. LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-fus-FSP1 complex.
Wang S; Chen J; Li P; Chen Y
Cell Death Dis; 2023 Nov; 14(11):767. PubMed ID: 38007473
[TBL] [Abstract] [Full Text] [Related]
6. Immunohistological analysis of B7-H4, IDO1, and PD-L1 expression and tumor immune microenvironment based on triple-negative breast cancer subtypes.
Sanuki F; Mikami Y; Nishimura H; Fujita Y; Monobe Y; Nomura T; Taira N; Moriya T
Breast Cancer; 2023 Nov; 30(6):1041-1053. PubMed ID: 37642903
[TBL] [Abstract] [Full Text] [Related]
7. [Diffuse large B-cell lymphoma of thyroid invading the superior mediastinum with hashimoto's thyroiditis: a case report and literature review].
Lv J; Yu T; Yin W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Sep; 37(9):755-758. PubMed ID: 37640999
[No Abstract] [Full Text] [Related]
8. DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma.
Fritchie KJ; Ameline B; Andrei V; Griffith C; Shah AA; Dermawan JK; Trucco M; Budd T; Thangaiah JJ; Molligan J; Whaley RD; Magliocca K; Azzato E; van Zante A; Jo V; Xu B; Bishop JA; Rooper L; Baumhoer D
Mod Pathol; 2023 Nov; 36(11):100301. PubMed ID: 37567448
[TBL] [Abstract] [Full Text] [Related]
9. Genetic Pathways in Peritoneal Mesothelioma Tumorigenesis.
Panagopoulos I; Andersen K; Brunetti M; Gorunova L; Davidson B; Lund-Iversen M; Micci F; Heim S
Cancer Genomics Proteomics; 2023; 20(4):363-374. PubMed ID: 37400148
[TBL] [Abstract] [Full Text] [Related]
10. B cells and tertiary lymphoid structures are associated with survival in papillary thyroid cancer.
Li YY; Li SJ; Liu MC; Chen Z; Li L; Shen F; Liu QZ; Xu B; Lian ZX
J Endocrinol Invest; 2023 Nov; 46(11):2247-2256. PubMed ID: 37004696
[TBL] [Abstract] [Full Text] [Related]
11. NR4A3 fusions characterize a distinctive peritoneal mesothelial neoplasm of uncertain biological potential with pure adenomatoid/microcystic morphology.
Agaimy A; Brcic L; Briski LM; Hung YP; Michal M; Michal M; Nielsen GP; Stoehr R; Rosenberg AE
Genes Chromosomes Cancer; 2023 May; 62(5):256-266. PubMed ID: 36524687
[TBL] [Abstract] [Full Text] [Related]
12. A novel fusion variant LSM14A::NR4A3 in extraskeletal myxoid chondrosarcoma.
Ngo C; Verret B; Vibert J; Cotteret S; Levy A; Pechoux CL; Haddag-Miliani L; Honore C; Faron M; Quinquis F; Cesne AL; Scoazec JY; Pierron G
Genes Chromosomes Cancer; 2023 Jan; 62(1):52-56. PubMed ID: 35932215
[TBL] [Abstract] [Full Text] [Related]
13. CD20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract] [Full Text] [Related]
14. SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the fus RNA binding protein (fus)/NUMB like endocytic adaptor protein (Numbl) axis.
Xin Y; Shang X; Sun X; Xu G; Liu Y; Liu Y
Bioengineered; 2022 May; 13(5):12572-12582. PubMed ID: 35599603
[TBL] [Abstract] [Full Text] [Related]
15. Fine needle aspiration cytology of primary thyroid non-hodgkins lymphoma: Experience from a tertiary care center of North India.
Singh M; Nain G; Jain S; Singh S; Malhotra V
J Cancer Res Ther; 2022; 18(1):185-189. PubMed ID: 35381782
[TBL] [Abstract] [Full Text] [Related]
16. Primary duodenal papilla lymphoma producing obstructive jaundice: a case report.
Wang J; Han J; Xu H; Tai S; Xie X
BMC Surg; 2022 Mar; 22(1):110. PubMed ID: 35321694
[TBL] [Abstract] [Full Text] [Related]
17. Robotic system for top to bottom MRgfus therapy of multiple cancer types.
Antoniou A; Giannakou M; Evripidou N; Stratis S; Pichardo S; Damianou C
Int J Med Robot; 2022 Apr; 18(2):e2364. PubMed ID: 34996126
[TBL] [Abstract] [Full Text] [Related]
18. SMARCA2-NR4A3 is a novel fusion gene of extraskeletal myxoid chondrosarcoma identified by RNA next-generation sequencing.
Wei S; Pei J; von Mehren M; Abraham JA; Patchefsky AS; Cooper HS
Genes Chromosomes Cancer; 2021 Oct; 60(10):709-712. PubMed ID: 34124809
[TBL] [Abstract] [Full Text] [Related]
19. The molecular mechanism of a novel derivative of BTO-956 induced apoptosis in human myelomonocytic lymphoma cells.
Li YL; Zhou DJ; Cui ZG; Sun L; Feng QW; Zakki SA; Hiraku Y; Wu CA; Inadera H
Apoptosis; 2021 Apr; 26(3-4):219-231. PubMed ID: 33738673
[TBL] [Abstract] [Full Text] [Related]
20. Trends in thyroid Surgery and Guideline-Concordant Care in the United States, 2007-2018.
Toumi A; DiGennaro C; Vahdat V; Jalali MS; Gazelle GS; Chhatwal J; Kelz RR; Lubitz CC
Thyroid; 2021 Jun; 31(6):941-949. PubMed ID: 33280499
[No Abstract] [Full Text] [Related]
[Next]
